Hospital
Salem Hospital Corporation
Salem Hospital Corporation was paid $3.56M by Medicaid between Jan 2018 and Jan 2019, across 132 billing codes. Its largest line is 99283, emergency room visit (moderate) — 34% of everything it billed.
33Billing provider infoSALEM HOSPITAL CORPORATION
SALEM, NJ 08079
SALEM, NJ 08079
33aNPI1306817978assigned 01/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.56M
24GClaims78,698
24DCodes billed132
24AFirst – last monthJan 2018 – Jan 2019
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#66 of 93
Median peer was paid$30.60M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74,102 | $3.34M | |
| 2019 | 4,596 | $217K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 4,931 | 4,574 | $1.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 2,747 | 2,441 | $597K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.7% | 1,307 | 1,200 | $237K |
| G0378 | Hospital observation service, per hour | 5.7% | 486 | 466 | $203K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 1,106 | 1,089 | $118K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.3% | 1,127 | 1,106 | $118K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 463 | 456 | $104K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 3,443 | 957 | $66K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 1,085 | 1,042 | $50K |
| OP370 | 1.4% | 537 | 527 | $50K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 2,263 | 1,983 | $48K |
| OP250 | <1% | 11,608 | 5,943 | $33K |
120 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,868 | $33K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,490 | $33K |
| 97010 | <1% | 1,091 | $29K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 901 | $28K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 856 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 700 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,035 | $24K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,361 | $24K |
| OP710 | <1% | 542 | $21K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,397 | $20K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 189 | $18K |
| 73564 | <1% | 408 | $17K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,078 | $15K |
| 84484 | <1% | 1,293 | $15K | |
| 82962 | <1% | 1,420 | $14K | |
| 97162 | <1% | 298 | $14K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 186 | $14K |
| 71045 | Radiologic examination, chest; single view | <1% | 748 | $13K |
| 82553 | <1% | 1,106 | $13K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 643 | $13K |
| 82550 | <1% | 1,175 | $13K | |
| 73630 | <1% | 427 | $12K | |
| 93971 | <1% | 53 | $12K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 270 | $11K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 133 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,041 | $10K |
| 76801 | <1% | 92 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 877 | $9K |
| 76830 | Ultrasound, transvaginal | <1% | 96 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 42 | $9K |
| 80053 | Comprehensive metabolic panel | <1% | 1,237 | $9K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 247 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 366 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 124 | $7K |
| 73030 | <1% | 258 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 406 | $7K |
| OP272 | <1% | 191 | $7K | |
| 73130 | <1% | 374 | $7K | |
| 73610 | <1% | 336 | $6K | |
| 83880 | <1% | 306 | $6K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 45 | $6K |
| 72100 | <1% | 202 | $6K | |
| 81001 | <1% | 2,483 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 77 | $5K |
| 72110 | <1% | 118 | $5K | |
| 73110 | <1% | 269 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 720 | $4K |
| 86850 | <1% | 173 | $4K | |
| 85610 | <1% | 529 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $4K |
| 83735 | <1% | 507 | $3K | |
| 84703 | <1% | 1,666 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 387 | $3K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 14 | $3K |
| 73502 | <1% | 111 | $3K | |
| 86900 | <1% | 195 | $2K | |
| 85027 | <1% | 401 | $2K | |
| 97161 | <1% | 62 | $2K | |
| 71250 | <1% | 25 | $2K | |
| 94760 | <1% | 38 | $2K | |
| 76770 | <1% | 26 | $2K | |
| 86901 | <1% | 194 | $2K | |
| 73562 | <1% | 127 | $2K | |
| 85730 | <1% | 302 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 181 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 181 | $2K |
| 83605 | <1% | 192 | $2K | |
| 74018 | <1% | 83 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 41 | $2K |
| 96376 | <1% | 89 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 259 | $2K |
| 80164 | <1% | 45 | $2K | |
| 81003 | <1% | 106 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 135 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 559 | $1K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 95 | $1K |
| 85379 | <1% | 194 | $1K | |
| 94664 | <1% | 25 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 330 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 239 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 86 | $1K |
| 83690 | <1% | 767 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 673 | $1K |
| 82248 | <1% | 145 | $1K | |
| OP255 | <1% | 175 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 432 | $1K |
| 80061 | Lipid panel | <1% | 120 | $1K |
| 80076 | <1% | 397 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 101 | $986.39 |
| 97116 | <1% | 26 | $862.88 | |
| 87040 | <1% | 147 | $769.16 | |
| 12001 | <1% | 26 | $726.63 | |
| 87081 | <1% | 315 | $714.83 | |
| 10060 | <1% | 26 | $664.52 | |
| 97165 | <1% | 27 | $644.76 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 202 | $567.87 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 57 | $553.80 |
| 72050 | <1% | 13 | $513.84 | |
| 90715 | <1% | 135 | $488.06 | |
| 73080 | <1% | 30 | $460.25 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 147 | $417.98 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 100 | $363.37 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 58 | $363.32 |
| 70486 | <1% | 12 | $338.94 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 50 | $327.85 |
| OP258 | <1% | 493 | $325.49 | |
| 84100 | <1% | 91 | $271.84 | |
| 74022 | <1% | 15 | $240.39 | |
| 87186 | <1% | 29 | $222.31 | |
| 73140 | <1% | 19 | $202.43 | |
| 84702 | <1% | 40 | $174.05 | |
| 87088 | <1% | 27 | $134.16 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 81 | $46.82 |
| 84439 | <1% | 13 | $41.91 | |
| 86140 | <1% | 14 | $19.09 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 230 | $12.58 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 35 | $9.44 |
| 85652 | <1% | 13 | $7.05 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 49 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 81 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.